Ann: Immutep Corporate Presentation, page-12

hmm i get that it is implying efti is causing the cd8 rise, but i dont think either graph actually shows that. the graph on the right is just at the 6 month timepoint, which shows more cd8 is correlated with better survival, but there isnt anything here to show me that efti is the cause of that cd8 increase. Just playing devils advocate that it could be the case that patients in the efti arm just naturally had more cd8 before getting dosed with efti, hence the baseline data would be so helpful to confirm or eliminate that possibility.

I am supportive of the company so i dont mean to come off skeptical, rather just wishing they had added two bars to the left graph on slide 17 to show that the two arms had equivalent cd8 at baseline before getting either treatment.